Skip to main content
Cidara Therapeutics, Inc. logo

Cidara Therapeutics, Inc. — Investor Relations & Filings

Ticker · CDTX ISIN · US1717572069 LEI · 549300IHQ9Z7RI1X2D22 US Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2020-06-26 Director's Dealing
Country US United States of America
Listing US CDTX

About Cidara Therapeutics, Inc.

https://www.cidara.com/

Cidara Therapeutics, Inc. is a biotechnology company that develops targeted immunotherapies and novel anti-infectives for patients with serious diseases. The company utilizes its proprietary Cloudbreak® platform to create drug-Fc conjugates (DFCs). These DFCs are engineered as 'single molecule cocktails' by coupling targeted small molecules or peptides to a human antibody fragment (Fc). This approach is designed to directly inhibit disease targets, such as fungal or viral pathogens, while simultaneously engaging the patient's immune system. The company's focus is on developing therapies for the treatment and prevention of life-threatening infections and other serious conditions.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2020-06-26 English
FORM 4
Director's Dealing
2020-06-26 English
FORM 4
Director's Dealing
2020-06-26 English
FORM 4
Director's Dealing
2020-06-26 English
FORM 4
Director's Dealing
2020-06-26 English
RESULTS OF ANNUAL MEETING OF STOCKHOLDERS
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated June 25, 2020, reporting the results of the Annual Meeting of Stockholders of Cidara Therapeutics, Inc. It includes detailed voting results for director elections and ratification of the independent auditor. The content focuses on the official results of shareholder votes at the annual meeting, which matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4072 characters, which is relatively short but contains substantive voting results, not just an announcement of a report. Therefore, it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). The key content is the voting results from the annual meeting, so the correct classification is DVA.
2020-06-25 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.